BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 6201722)

  • 1. Adenovirus VA RNAI: a positive regulator of mRNA translation.
    Svensson C; Akusjärvi G
    Mol Cell Biol; 1984 Apr; 4(4):736-42. PubMed ID: 6201722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenovirus VA RNAI mediates a translational stimulation which is not restricted to the viral mRNAs.
    Svensson C; Akusjärvi G
    EMBO J; 1985 Apr; 4(4):957-64. PubMed ID: 2410262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defective RNA splicing in the absence of adenovirus-associated RNAI.
    Svensson C; Akusjärvi G
    Proc Natl Acad Sci U S A; 1986 Jul; 83(13):4690-4. PubMed ID: 3460065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of a low-molecular-weight virus-associated (VA) RNA encoded by simian adenovirus type 7 which functionally can substitute for adenovirus type 5 VA RNAI.
    Larsson S; Svensson C; Akusjärvi G
    J Virol; 1986 Nov; 60(2):635-44. PubMed ID: 3773054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenovirus tripartite leader sequence enhances translation of mRNAs late after infection.
    Logan J; Shenk T
    Proc Natl Acad Sci U S A; 1984 Jun; 81(12):3655-9. PubMed ID: 6587381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of the components necessary for adenovirus translational control and their utilization in cDNA expression vectors.
    Kaufman RJ
    Proc Natl Acad Sci U S A; 1985 Feb; 82(3):689-93. PubMed ID: 2983309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two adenovirus proteins with redundant activities in virus growth facilitates tripartite leader mRNA accumulation.
    Ohman K; Nordqvist K; Akusjärvi G
    Virology; 1993 May; 194(1):50-8. PubMed ID: 8386890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anatomy of region L1 from adenovirus type 2.
    Akusjärvi G
    J Virol; 1985 Dec; 56(3):879-86. PubMed ID: 2415717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of the translation defect phenotype specific for a virus-associated RNA-deficient adenovirus mutant in monkey cells by simian virus 40.
    Subramanian S; Bhat RA; Rundell MK; Thimmappaya B
    J Virol; 1986 Nov; 60(2):363-8. PubMed ID: 3021970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complementation of the human adenovirus type 5 VA RNAI defect by the Vaccinia virus E3L protein and serotype-specific VA RNAIs.
    Inturi R; Kamel W; Akusjärvi G; Punga T
    Virology; 2015 Nov; 485():25-35. PubMed ID: 26196231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The adenovirus tripartite leader sequence can alter nuclear and cytoplasmic metabolism of a non-adenovirus mRNA within infected cells.
    Moore MA; Shenk T
    Nucleic Acids Res; 1988 Mar; 16(5):2247-62. PubMed ID: 3357776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The adenovirus tripartite leader may eliminate the requirement for cap-binding protein complex during translation initiation.
    Dolph PJ; Racaniello V; Villamarin A; Palladino F; Schneider RJ
    J Virol; 1988 Jun; 62(6):2059-66. PubMed ID: 2835510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of RNA interference by adenovirus virus-associated RNA.
    Andersson MG; Haasnoot PC; Xu N; Berenjian S; Berkhout B; Akusjärvi G
    J Virol; 2005 Aug; 79(15):9556-65. PubMed ID: 16014917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenovirus VAI RNA is required for efficient translation of viral mRNAs at late times after infection.
    Thimmappaya B; Weinberger C; Schneider RJ; Shenk T
    Cell; 1982 Dec; 31(3 Pt 2):543-51. PubMed ID: 6297772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Translation by the adenovirus tripartite leader: elements which determine independence from cap-binding protein complex.
    Dolph PJ; Huang JT; Schneider RJ
    J Virol; 1990 Jun; 64(6):2669-77. PubMed ID: 1692346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The tripartite leader sequence of subgroup C adenovirus major late mRNAs can increase the efficiency of mRNA export.
    Huang W; Flint SJ
    J Virol; 1998 Jan; 72(1):225-35. PubMed ID: 9420219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of RISC-associated adenoviral microRNAs, a subset of their direct targets, and global changes in the targetome upon lytic adenovirus 5 infection.
    Bellutti F; Kauer M; Kneidinger D; Lion T; Klein R
    J Virol; 2015 Feb; 89(3):1608-27. PubMed ID: 25410853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The spliced structures of adenovirus 2 fiber message and the other late mRNAs.
    Chow LT; Broker TR
    Cell; 1978 Oct; 15(2):497-510. PubMed ID: 719751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Method for introducing site-specific mutations into adenovirus 2 genome: construction of a small deletion mutant in VA-RNAI gene.
    Kapoor QS; Chinnadurai G
    Proc Natl Acad Sci U S A; 1981 Apr; 78(4):2184-8. PubMed ID: 6941277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The gene and messenger RNA for adenovirus polypeptide IX.
    Pettersson U; Mathews MB
    Cell; 1977 Nov; 12(3):741-50. PubMed ID: 922891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.